Literature DB >> 6220082

Effects of C-reactive protein on human lymphocyte responsiveness.

M L Vetter, H Gewurz, B Hansen, K James, L L Baum.   

Abstract

C-reactive protein (CRP), a trace serum protein that increases markedly in concentration during inflammatory reactions, was recently shown to bind to a subset of human IgG-FcR-bearing peripheral blood lymphocytes in the presence of a ligand such as pneumococcal C-polysaccharide (CPS). CRP has also been detected on a small percentage of PBL that are associated with NK activity. In the present study, we assessed the effects of CRP and CRP-CPS complexes on a variety of human lymphocyte functions in vitro. CRP and CRP complexes significantly enhanced (generally two to threefold) cell-mediated cytotoxicity, minimally enhanced the MLC reaction, and induced a small but regularly detectable blastogenic response in resting PBL. CRP or CRP-CPS complexes had no effect on mitogen-induced blastogenesis, PWM-induced generation of IgM plaque-forming cells, E-rosette formation, antibody-dependent cell-mediated cytotoxicity, or NK activity. The basis for the preferential ability of CRP to enhance cytotoxicity responses in vitro is under further investigation.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6220082

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  The role of phosphate groups in the interaction of human C-reactive protein with galactan polysaccharides.

Authors:  J Soelter; G Uhlenbruck
Journal:  Immunology       Date:  1986-05       Impact factor: 7.397

2.  C-reactive protein in patients with lymphatic filariasis: increased expression on lymphocytes in chronic lymphatic obstruction.

Authors:  R B Lal; R R Dhawan; R M Ramzy; R M Farris; A A Gad
Journal:  J Clin Immunol       Date:  1991-01       Impact factor: 8.317

3.  Preoperative elevation of serum C-reactive protein as an independent prognostic indicator of colorectal carcinoma.

Authors:  Tadahiro Nozoe; Emiko Mori; Ikuo Takahashi; Takahiro Ezaki
Journal:  Surg Today       Date:  2008-07-09       Impact factor: 2.549

4.  C-reactive protein is involved in natural killer cell-mediated lysis but does not mediate effector-target cell recognition.

Authors:  L L Baum; B Johnson; S Berman; D Graham; C Mold
Journal:  Immunology       Date:  1987-05       Impact factor: 7.397

5.  Stimulation of human neutrophils, monocytes, and platelets by modified C-reactive protein (CRP) expressing a neoantigenic specificity.

Authors:  L A Potempa; J M Zeller; B A Fiedel; C M Kinoshita; H Gewurz
Journal:  Inflammation       Date:  1988-08       Impact factor: 4.092

6.  Acute phase proteins and recombinant IL-2 therapy: prediction of response and survival in patients with colorectal cancer.

Authors:  W G Simpson; S D Heys; P H Whiting; O Eremin; J Broom
Journal:  Clin Exp Immunol       Date:  1995-02       Impact factor: 4.330

7.  Binding sites for C-reactive protein on human monocytes are distinct from IgG Fc receptors.

Authors:  J M Zeller; B M Kubak; H Gewurz
Journal:  Immunology       Date:  1989-05       Impact factor: 7.397

8.  The acute phase response in parasite infection. Nippostrongylus brasiliensis in the mouse.

Authors:  L R Lamontagne; J Gauldie; A D Befus; K P McAdam; M L Baltz; M B Pepys
Journal:  Immunology       Date:  1984-08       Impact factor: 7.397

9.  C-reactive Protein and Disease Outcome in Nigerian Sickle Cell Disease Patients.

Authors:  Ce Okocha; Po Manafa; Jo Ozomba; To Ulasi; Go Chukwuma; Jc Aneke
Journal:  Ann Med Health Sci Res       Date:  2014-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.